<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38399482</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Microvascular Capillary and Precapillary Cardiovascular Disturbances Strongly Interact to Severely Affect Tissue Perfusion and Mitochondrial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Evolving from the Post COVID-19 Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">194</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina60020194</ELocationID><Abstract><AbstractText>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a frequent, debilitating and still enigmatic disease. There is a broad overlap in the symptomatology of ME/CFS and the Post-COVID-19 Syndrome (PCS). A fraction of the PCS patients develop the full clinical picture of ME/CFS. New observations in microvessels and blood from patients suffering from PCS have appeared and include microclots and malformed pathological blood cells. Capillary blood flow is impaired not only by pathological blood components but also by prothrombotic changes in the vascular wall, endothelial dysfunction, and the expression of adhesion molecules in the capillaries. These disturbances can finally cause a low capillary flow and even capillary stasis. A low cardiac stroke volume due to hypovolemia and the inability of the capacitance vessels to adequately constrict to deliver the necessary cardiac preload generate an unfavorable low precapillary perfusion pressure. Furthermore, a predominance of vasoconstrictor over vasodilator influences exists, in which sympathetic hyperactivity and endothelial dysfunction play a strong role, causing the constriction of resistance vessels and of precapillary sphincters, which leads to a fall in capillary pressure behind the sphincters. The interaction of these two precapillary cardiovascular mechanisms causing a low capillary perfusion pressure is hemodynamically highly unfavorable in the presence of a primary capillary stasis, which is already caused by the pathological blood components and their interaction with the capillary wall, to severely impair organ perfusion. The detrimental coincidence of microcirculatory and precapillary cardiovascular disturbances may constitute the key disturbance of the Post-COVID-19 syndrome and finally lead to ME/CFS in predisposed patients because the interaction causes a particular kind of perfusion disturbance-capillary ischemia/reperfusion-which has a high potential of causing mitochondrial dysfunction by inducing sodium- and calcium-overload in skeletal muscles. The latter, in turn, worsens the vascular situation through the generation of reactive oxygen species to close a vicious cycle from which the patient can hardly escape.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wirth</LastName><ForeName>Klaus Josef</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>Institute of General Pharmacology and Toxicology, University Hospital Frankfurt am Main, Goethe-University, Theodor-Stern Kai 7, D-60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;hn</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4120-3544</Identifier><AffiliationInfo><Affiliation>Institute of General Pharmacology and Toxicology, University Hospital Frankfurt am Main, Goethe-University, Theodor-Stern Kai 7, D-60590 Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002196" MajorTopicYN="N">Capillaries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="N">Microcirculation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010477" MajorTopicYN="N">Perfusion</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">capillary disturbances</Keyword><Keyword MajorTopicYN="N">exercise intolerance</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mitochondrial dysfunction</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">post-exertional malaise</Keyword><Keyword MajorTopicYN="N">precapillary cardiovascular disturbances</Keyword><Keyword MajorTopicYN="N">&#xdf;2AdR dysfunction</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>11</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38399482</ArticleId><ArticleId IdType="pmc">PMC10890404</ArticleId><ArticleId IdType="doi">10.3390/medicina60020194</ArticleId><ArticleId IdType="pii">medicina60020194</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dixit N.M., Churchill A., Nsair A., Hsu J.J. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am. Heart J. Plus. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Lohn M. Orthostatic Intolerance after COVID-19 Infection: Is Disturbed Microcirculation of the Vasa Vasorum of Capacitance Vessels the Primary Defect? Medicina. 2022;58:1807. doi: 10.3390/medicina58121807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58121807</ArticleId><ArticleId IdType="pmc">PMC9788017</ArticleId><ArticleId IdType="pubmed">36557009</ArticleId></ArticleIdList></Reference><Reference><Citation>Legler F., Meyer-Arndt L., Modl L., Kedor C., Freitag H., Stein E., Hoppmann U., Rust R., Wittke K., Siebert N., et al. Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: Results from a prospective observational cohort. eClinicalMedicine. 2023;63:102146. doi: 10.1016/j.eclinm.2023.102146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102146</ArticleId><ArticleId IdType="pmc">PMC10469383</ArticleId><ArticleId IdType="pubmed">37662515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubankova M., Hohberger B., Hoffmanns J., Furst J., Herrmann M., Guck J., Krater M. Physical phenotype of blood cells is altered in COVID-19. Biophys. J. 2021;120:2838&#x2013;2847. doi: 10.1016/j.bpj.2021.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.025</ArticleId><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Berk M., Galecki P., Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs) Mol. Neurobiol. 2014;49:741&#x2013;756. doi: 10.1007/s12035-013-8553-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8553-0</ArticleId><ArticleId IdType="pubmed">24068616</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha A.K., Schmidt B.R., Wilhelmy J., Nguyen V., Abugherir A., Do J.K., Nemat-Gorgani M., Davis R.W., Ramasubramanian A.K. Red blood cell deformability is diminished in patients with Chronic Fatigue Syndrome. Clin. Hemorheol. Microcirc. 2019;71:113&#x2013;116. doi: 10.3233/CH-180469.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-180469</ArticleId><ArticleId IdType="pmc">PMC6398549</ArticleId><ArticleId IdType="pubmed">30594919</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch N., du Preez S., Cabanas H., Staines D., Marshall-Gradisnik S. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome. Syst. Rev. 2019;8:279. doi: 10.1186/s13643-019-1202-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-019-1202-6</ArticleId><ArticleId IdType="pmc">PMC6857215</ArticleId><ArticleId IdType="pubmed">31727160</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kruger A., Proal A., Kell D.B., Pretorius E. The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Pharmaceuticals. 2022;15:931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B.H., Brunjes D.L., Mancini D. Chronic Fatigue Syndrome and Cardiovascular Disease: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 2021;78:1056&#x2013;1067. doi: 10.1016/j.jacc.2021.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.06.045</ArticleId><ArticleId IdType="pubmed">34474739</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilazi M., Duffy E.Y., Thakkar A., Michos E.D. COVID and Cardiovascular Disease: What We Know in 2021. Curr. Atheroscler. Rep. 2021;23:37. doi: 10.1007/s11883-021-00935-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-021-00935-2</ArticleId><ArticleId IdType="pmc">PMC8117457</ArticleId><ArticleId IdType="pubmed">33983522</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy E., Chilazi M., Cainzos-Achirica M., Michos E.D. Cardiovascular Disease Prevention During the COVID-19 Pandemic: Lessons Learned and Future Opportunities. Methodist. Debakey. Cardiovasc. J. 2021;17:68&#x2013;78. doi: 10.14797/mdcvj.210.</Citation><ArticleIdList><ArticleId IdType="doi">10.14797/mdcvj.210</ArticleId><ArticleId IdType="pmc">PMC8588760</ArticleId><ArticleId IdType="pubmed">34824683</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K., Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ss2-adrenergic receptors. Autoimmun. Rev. 2020;19:102527. doi: 10.1016/j.autrev.2020.102527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType="pubmed">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Lohn M. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Comorbidities: Linked by Vascular Pathomechanisms and Vasoactive Mediators? Medicina. 2023;59:978. doi: 10.3390/medicina59050978.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina59050978</ArticleId><ArticleId IdType="pmc">PMC10224216</ArticleId><ArticleId IdType="pubmed">37241210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C., Paul F. An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Transl. Med. 2021;19:471. doi: 10.1186/s12967-021-03143-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03143-3</ArticleId><ArticleId IdType="pmc">PMC8607226</ArticleId><ArticleId IdType="pubmed">34809664</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin M., Sanal-Hayes N.E.M., Hayes L.D., Berry E.C., Sculthorpe N.F. People with Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Exhibit Similarly Impaired Vascular Function. Am. J. Med. 2023. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.09.013</ArticleId><ArticleId IdType="pubmed">37832757</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Arevalo C., Oliveira R.K.F., Faria-Urbina M., Felsenstein D., Oaklander A.L., Systrom D.M. Insights From Invasive Cardiopulmonary Exercise Testing of Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Chest. 2021;160:642&#x2013;651. doi: 10.1016/j.chest.2021.01.082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.01.082</ArticleId><ArticleId IdType="pmc">PMC8727854</ArticleId><ArticleId IdType="pubmed">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuorilehto T., Poyhonen M., Keski-Nisula L., Laurikka J., Salenius J.P. Vascular malformations associated with Marfan syndrome, Ehlers-Danlos syndrome and neurofibromatosis 1 and their surgical treatment. Duodecim. 2011;127:2280&#x2013;2286.</Citation><ArticleIdList><ArticleId IdType="pubmed">22204142</ArticleId></ArticleIdList></Reference><Reference><Citation>Meester J.A.N., Verstraeten A., Schepers D., Alaerts M., Van Laer L., Loeys B.L. Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Ann. Cardiothorac. Surg. 2017;6:582&#x2013;594. doi: 10.21037/acs.2017.11.03.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/acs.2017.11.03</ArticleId><ArticleId IdType="pmc">PMC5721110</ArticleId><ArticleId IdType="pubmed">29270370</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M., Chang C., Gershwin M.E. Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons. J. Transl. Autoimmun. 2021;4:100077. doi: 10.1016/j.jtauto.2020.100077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2020.100077</ArticleId><ArticleId IdType="pmc">PMC7786113</ArticleId><ArticleId IdType="pubmed">33437956</ArticleId></ArticleIdList></Reference><Reference><Citation>Roma M., Marden C.L., De Wandele I., Francomano C.A., Rowe P.C. Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome. Auton. Neurosci. 2018;215:89&#x2013;96. doi: 10.1016/j.autneu.2018.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.02.006</ArticleId><ArticleId IdType="pubmed">29519641</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe P.C., Barron D.F., Calkins H., Maumenee I.H., Tong P.Y., Geraghty M.T. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J. Pediatr. 1999;135:494&#x2013;499. doi: 10.1016/S0022-3476(99)70173-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(99)70173-3</ArticleId><ArticleId IdType="pubmed">10518084</ArticleId></ArticleIdList></Reference><Reference><Citation>Campen C., Rowe P.C., Visser F.C. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Medicina. 2021;58:28. doi: 10.3390/medicina58010028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Rowe P.C., Visser F.C. Deconditioning does not explain orthostatic intolerance in ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) J. Transl. Med. 2021;19:193. doi: 10.1186/s12967-021-02819-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02819-0</ArticleId><ArticleId IdType="pmc">PMC8097965</ArticleId><ArticleId IdType="pubmed">33947430</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Verheugt F.W.A., Rowe P.C., Visser F.C. Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) IBRO Neurosci. Rep. 2023;15:1&#x2013;10. doi: 10.1016/j.ibneur.2023.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibneur.2023.04.005</ArticleId><ArticleId IdType="pmc">PMC10250802</ArticleId><ArticleId IdType="pubmed">37303862</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller-Ruchholtz E.R., Losch H.M., Grund E., Lochner W. Effect of alpha adrenergic receptor stimulation on integrated systemic venous bed. Pflug. Arch. 1977;370:241&#x2013;246. doi: 10.1007/BF00585533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00585533</ArticleId><ArticleId IdType="pubmed">22062</ArticleId></ArticleIdList></Reference><Reference><Citation>Coupar I.M. The effect of isoprenaline on adrenoceptors in human saphenous vein. Br. J. Pharmacol. 1970;39:465&#x2013;475. doi: 10.1111/j.1476-5381.1970.tb10355.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.1970.tb10355.x</ArticleId><ArticleId IdType="pmc">PMC1702622</ArticleId><ArticleId IdType="pubmed">4394337</ArticleId></ArticleIdList></Reference><Reference><Citation>Dachman W.D., Bedarida G., Blaschke T.F., Hoffman B.B. Histamine-induced venodilation in human beings involves both H1 and H2 receptor subtypes. J. Allergy Clin. Immunol. 1994;93:606&#x2013;614. doi: 10.1016/S0091-6749(94)70072-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0091-6749(94)70072-9</ArticleId><ArticleId IdType="pubmed">8151062</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller-Schweinitzer E. On the pharmacology of venous smooth muscle from dog and man. Folia. Haematol. Int. Mag. Klin. Morphol. Blutforsch. 1979;106:690&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">94863</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock L.B., Brook J.B., Walters A.S., Goris A., Afrin L.B., Molderings G.J. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P., Tahmasebi N., Gant V., Gupta R. Long COVID following mild SARS-CoV-2 infection: Characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashauri H.L. COVID-19 Histamine theory: Why antihistamines should be incorporated as the basic component in COVID-19 management? Health Sci. Rep. 2023;6:e1109. doi: 10.1002/hsr2.1109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1109</ArticleId><ArticleId IdType="pmc">PMC9903129</ArticleId><ArticleId IdType="pubmed">36778771</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu C., Fuhler G.M., Pan Y. Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19? Int. J. Mol. Sci. 2021;22:5672. doi: 10.3390/ijms22115672.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115672</ArticleId><ArticleId IdType="pmc">PMC8199351</ArticleId><ArticleId IdType="pubmed">34073529</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto M.D., Lambert N., Downs C.A., Abrahim H., Hughes T.D., Rahmani A.M., Burton C.W., Chakraborty R. Antihistamines for Postacute Sequelae of SARS-CoV-2 Infection. J. Nurse Pract. 2022;18:335&#x2013;338. doi: 10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="pubmed">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvucci F., Codella R., Coppola A., Zacchei I., Grassi G., Anti M.L., Nitisoara N., Luzi L., Gazzaruso C. Antihistamines improve cardiovascular manifestations and other symptoms of long-COVID attributed to mast cell activation. Front. Cardiovasc. Med. 2023;10:1202696. doi: 10.3389/fcvm.2023.1202696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1202696</ArticleId><ArticleId IdType="pmc">PMC10388239</ArticleId><ArticleId IdType="pubmed">37529714</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivri F., Turkoz I., Sencan M., Icen Y.K., Aksoy F., Ceyhan B.O. Does COVID-19 Cause Non-Dipper Hypertension? Angiology. 2023:33197231209584. doi: 10.1177/00033197231209584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231209584</ArticleId><ArticleId IdType="pubmed">37864346</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Brinth L., Hendrickson J.E., Martinez-Lavin M. Autonomic dysfunction and HPV immunization: An overview. Immunol. Res. 2018;66:744&#x2013;754. doi: 10.1007/s12026-018-9036-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-018-9036-1</ArticleId><ArticleId IdType="pubmed">30478703</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B. Prevalence of readily detected amyloid blood clots in &#x2018;unclotted&#x2019; Type 2 Diabetes Mellitus and COVID-19 plasma: A preliminary report. Cardiovasc. Diabetol. 2020;19:193. doi: 10.1186/s12933-020-01165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlick S., Lucio M., Wallukat G., Bartsch A., Skornia A., Hoffmanns J., Szewczykowski C., Schroder T., Raith F., Rogge L., et al. Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue. Int. J. Mol. Sci. 2022;23:13683. doi: 10.3390/ijms232213683.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232213683</ArticleId><ArticleId IdType="pmc">PMC9690863</ArticleId><ArticleId IdType="pubmed">36430175</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Connors J.M., Levy J.H. What Role Does Microthrombosis Play in Long COVID? Semin. Thromb. Hemost. 2023. Epub ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1774795</ArticleId><ArticleId IdType="pubmed">37748518</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschman T., Wyler E., Baum O., Hentschel A., Rust R., Legler F., Preusse C., Meyer-Arndt L., Buttnerova I., Forster A., et al. Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles. Acta Neuropathol. Commun. 2023;11:193. doi: 10.1186/s40478-023-01662-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-023-01662-2</ArticleId><ArticleId IdType="pmc">PMC10704838</ArticleId><ArticleId IdType="pubmed">38066589</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I., Schulze A., Evers G., Harmening K., Vink H., Kumpers P., Mohr M., Rovas A. Persistent capillary rarefication in long COVID syndrome. Angiogenesis. 2023;26:53&#x2013;61. doi: 10.1007/s10456-022-09850-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene A.S., Tonellato P.J., Lui J., Lombard J.H., Cowley A.W., Jr. Microvascular rarefaction and tissue vascular resistance in hypertension. Am. J. Physiol. 1989;256:H126&#x2013;H131. doi: 10.1152/ajpheart.1989.256.1.H126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1989.256.1.H126</ArticleId><ArticleId IdType="pubmed">2912175</ArticleId></ArticleIdList></Reference><Reference><Citation>Nusz D.J., White D.C., Dai Q., Pippen A.M., Thompson M.A., Walton G.B., Parsa C.J., Koch W.J., Annex B.H. Vascular rarefaction in peripheral skeletal muscle after experimental heart failure. Am. J. Physiol. Heart Circ. Physiol. 2003;285:H1554&#x2013;H1562. doi: 10.1152/ajpheart.01045.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.01045.2002</ArticleId><ArticleId IdType="pubmed">12969880</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z.Y., Barnden L.R., Kwiatek R.A., Bhuta S., Hermens D.F., Lagopoulos J. Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systematic review. J. Transl. Med. 2020;18:335. doi: 10.1186/s12967-020-02506-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02506-6</ArticleId><ArticleId IdType="pmc">PMC7466519</ArticleId><ArticleId IdType="pubmed">32873297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Z.Y., Mohamed A.Z., Andersen T., Rendall S., Kwiatek R.A., Fante P.D., Calhoun V.D., Bhuta S., Lagopoulos J. Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis. Front. Neurol. 2022;13:954142. doi: 10.3389/fneur.2022.954142.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.954142</ArticleId><ArticleId IdType="pmc">PMC9523103</ArticleId><ArticleId IdType="pubmed">36188362</ArticleId></ArticleIdList></Reference><Reference><Citation>Adingupu D.D., Soroush A., Hansen A., Twomey R., Dunn J.F. Reduced Cerebrovascular Oxygenation in Individuals with Post-Acute COVID-19 Syndrome (PACS) (&#x201c;long COVID&#x201d;) Adv. Exp. Med. Biol. 2023;1438:211&#x2013;216. doi: 10.1007/978-3-031-42003-0_33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-031-42003-0_33</ArticleId><ArticleId IdType="pubmed">37845463</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Rowe P.C., Visser F.C. Blood Volume Status in ME/CFS Correlates With the Presence or Absence of Orthostatic Symptoms: Preliminary Results. Front. Pediatr. 2018;6:352. doi: 10.3389/fped.2018.00352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00352</ArticleId><ArticleId IdType="pmc">PMC6262290</ArticleId><ArticleId IdType="pubmed">30525014</ArticleId></ArticleIdList></Reference><Reference><Citation>Guven G., Hilty M.P., Ince C. Microcirculation: Physiology, Pathophysiology, and Clinical Application. Blood Purif. 2020;49:143&#x2013;150. doi: 10.1159/000503775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000503775</ArticleId><ArticleId IdType="pmc">PMC7114900</ArticleId><ArticleId IdType="pubmed">31851980</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibn Hadj Amor H., Jdidi J., Torjmen S., Kraiem S., Hammami R., Bahloul A., Kallel N., Moussa N., Touil I., et al. Long COVID 19 Syndrome: Is It Related to Microcirculation and Endothelial Dysfunction? Insights From TUN-EndCOV Study. Front. Cardiovasc. Med. 2021;8:745758. doi: 10.3389/fcvm.2021.745758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Jannasz I., Pruc M., Rahnama-Hezavah M., Targowski T., Olszewski R., Feduniw S., Petryka K., Szarpak L. The Impact of COVID-19 on Carotid-Femoral Pulse Wave Velocity: A Systematic Review and Meta-Analysis. J. Clin. Med. 2023;12:5747. doi: 10.3390/jcm12175747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12175747</ArticleId><ArticleId IdType="pmc">PMC10488425</ArticleId><ArticleId IdType="pubmed">37685813</ArticleId></ArticleIdList></Reference><Reference><Citation>Mali W., Doevendans P.A. Form and function, both matter. Neth. Heart J. 2015;23:312&#x2013;313. doi: 10.1007/s12471-015-0686-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12471-015-0686-5</ArticleId><ArticleId IdType="pmc">PMC4446273</ArticleId><ArticleId IdType="pubmed">25920514</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke M. Arterial stiffness, systolic blood pressure, and logical treatment of arterial hypertension. Hypertension. 1990;15:339&#x2013;347. doi: 10.1161/01.HYP.15.4.339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.HYP.15.4.339</ArticleId><ArticleId IdType="pubmed">2180816</ArticleId></ArticleIdList></Reference><Reference><Citation>Day H., Yellman B., Hammer S., Rond C., Bell J., Abbaszadeh S., Stoddard G., Unutmaz D., Bateman L., Vernon S.D. Cognitive impairment in post-acute sequelae of COVID-19 and short duration myalgic encephalomyelitis patients is mediated by orthostatic hemodynamic changes. Front. Neurosci. 2023;17:1203514. doi: 10.3389/fnins.2023.1203514.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2023.1203514</ArticleId><ArticleId IdType="pmc">PMC10330752</ArticleId><ArticleId IdType="pubmed">37434760</ArticleId></ArticleIdList></Reference><Reference><Citation>Tas S., Tas U. Effects of COVID-19 on the Autonomic Cardiovascular System: Heart Rate Variability and Turbulence in Recovered Patients. Tex. Heart Inst. J. 2023;50:e227952. doi: 10.14503/THIJ-22-7952.</Citation><ArticleIdList><ArticleId IdType="doi">10.14503/THIJ-22-7952</ArticleId><ArticleId IdType="pmc">PMC10660136</ArticleId><ArticleId IdType="pubmed">37605870</ArticleId></ArticleIdList></Reference><Reference><Citation>Delle Donne G., Roses Noguer F., Till J., Salukhe T., Prasad S.K., Daubeney P.E.F. Ivabradine in Postural Orthostatic Tachycardia Syndrome: Preliminary Experience in Children. Am. J. Cardiovasc. Drugs. 2018;18:59&#x2013;63. doi: 10.1007/s40256-017-0248-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40256-017-0248-x</ArticleId><ArticleId IdType="pubmed">29027608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir F., Bin Arif T., Majid Z., Ahmed J., Khalid M. Ivabradine in Postural Orthostatic Tachycardia Syndrome: A Review of the Literature. Cureus. 2020;12:e7868. doi: 10.7759/cureus.7868.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.7868</ArticleId><ArticleId IdType="pmc">PMC7255540</ArticleId><ArticleId IdType="pubmed">32489723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzieh M., Sirianni N., Ammari Z., Dasa O., Alhazmi L., Karabin B., Grubb B. Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience. Pacing Clin. Electrophysiol. 2017;40:1242&#x2013;1245. doi: 10.1111/pace.13182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pace.13182</ArticleId><ArticleId IdType="pubmed">28846151</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzilai M., Jacob G. The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients. Rambam. Maimonides Med. J. 2015;6:e0028. doi: 10.5041/RMMJ.10213.</Citation><ArticleIdList><ArticleId IdType="doi">10.5041/RMMJ.10213</ArticleId><ArticleId IdType="pmc">PMC4524401</ArticleId><ArticleId IdType="pubmed">26241226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacasa M., Launois P., Prados F., Alegre J., Casas-Roma J. Unsupervised cluster analysis reveals distinct subtypes of ME/CFS patients based on peak oxygen consumption and SF-36 scores. Clin. Ther. 2023;45:1228&#x2013;1235. doi: 10.1016/j.clinthera.2023.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2023.09.007</ArticleId><ArticleId IdType="pubmed">37802746</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K.J., Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) J. Transl. Med. 2021;19:162. doi: 10.1186/s12967-021-02833-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType="pmc">PMC8058748</ArticleId><ArticleId IdType="pubmed">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>Avkiran M., Gross G., Karmazyn M., Klein H., Murphy E., Ytrehus K. Na+/H+ exchange in ischemia, reperfusion and preconditioning. Cardiovasc. Res. 2001;50:162&#x2013;166. doi: 10.1016/S0008-6363(01)00228-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(01)00228-0</ArticleId><ArticleId IdType="pubmed">11345942</ArticleId></ArticleIdList></Reference><Reference><Citation>Karmazyn M., Sawyer M., Fliegel L. The Na+/H+ exchanger: A target for cardiac therapeutic intervention. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2005;5:323&#x2013;335. doi: 10.2174/1568006054553417.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568006054553417</ArticleId><ArticleId IdType="pubmed">16101565</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen T. Na+-K+ Pump Regulation and Skeletal Muscle Contractility. Physiol. Rev. 2003;83:1269&#x2013;1324. doi: 10.1152/physrev.00011.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00011.2003</ArticleId><ArticleId IdType="pubmed">14506306</ArticleId></ArticleIdList></Reference><Reference><Citation>Petter E., Scheibenbogen C., Linz P., Stehning C., Wirth K., Kuehne T., Kelm M. Muscle sodium content in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J. Transl. Med. 2022;20:580. doi: 10.1186/s12967-022-03616-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03616-z</ArticleId><ArticleId IdType="pmc">PMC9733289</ArticleId><ArticleId IdType="pubmed">36494667</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirkmajer S., Chibalin A.V. Na,K-ATPase regulation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2016;311:E1&#x2013;E31. doi: 10.1152/ajpendo.00539.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00539.2015</ArticleId><ArticleId IdType="pubmed">27166285</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen T. Quantification of Na+,K+ pumps and their transport rate in skeletal muscle: Functional significance. J. Gen. Physiol. 2013;142:327&#x2013;345. doi: 10.1085/jgp.201310980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1085/jgp.201310980</ArticleId><ArticleId IdType="pmc">PMC3787770</ArticleId><ArticleId IdType="pubmed">24081980</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotecchia S., Stanasila L., Diviani D. Protein-protein interactions at the adrenergic receptors. Curr. Drug Targets. 2012;13:15&#x2013;27. doi: 10.2174/138945012798868489.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138945012798868489</ArticleId><ArticleId IdType="pmc">PMC3290771</ArticleId><ArticleId IdType="pubmed">21777184</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Nolano M. Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review. JAMA Neurol. 2019;76:1240&#x2013;1251. doi: 10.1001/jamaneurol.2019.2917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2917</ArticleId><ArticleId IdType="pmc">PMC10021074</ArticleId><ArticleId IdType="pubmed">31498378</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams R.M.C., Simpson D.M., Navis A., Jette N., Zhou L., Shin S.C. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022;65:440&#x2013;443. doi: 10.1002/mus.27458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27458</ArticleId><ArticleId IdType="pmc">PMC8661991</ArticleId><ArticleId IdType="pubmed">34766365</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., Toran L.S., Smith B., Dalakas M.C., Nath A. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID. Neurol. Neuroimmunol. Neuroinflamm. 2022;9 doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain S.D., Cox H.M. Neuropeptides and their receptors: Innovative science providing novel therapeutic targets. Br. J. Pharmacol. 2006;147:S202&#x2013;S211. doi: 10.1038/sj.bjp.0706461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0706461</ArticleId><ArticleId IdType="pmc">PMC1760747</ArticleId><ArticleId IdType="pubmed">16402106</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen O.B., Hilsted L., Fau-Clausen T., Clausen T. Excitation-induced force recovery in potassium-inhibited rat soleus muscle. J. Physiol. 1998;512:819&#x2013;829. doi: 10.1111/j.1469-7793.1998.819bd.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1998.819bd.x</ArticleId><ArticleId IdType="pmc">PMC2231245</ArticleId><ArticleId IdType="pubmed">9769424</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L.M.C., Wintjens M., Nagy M., Willems L., Ten Cate H., Spronk H.M.H., van Kuijk S.M.J., Ghossein-Doha C., Netea M.G., Groh L.A., et al. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection. Front. Immunol. 2023;14:1182182. doi: 10.3389/fimmu.2023.1182182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1182182</ArticleId><ArticleId IdType="pmc">PMC10586198</ArticleId><ArticleId IdType="pubmed">37868959</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunter T.E., Yule D.I., Gunter K.K., Eliseev R.A., Salter J.D. Calcium and mitochondria. FEBS Lett. 2004;567:96&#x2013;102. doi: 10.1016/j.febslet.2004.03.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2004.03.071</ArticleId><ArticleId IdType="pubmed">15165900</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y., Adjriou N., Kipson N., Criado C., Charpin C., Rebaudet S., Stavris C., Guieu R., Fenouillet E., Retornaz F. Altered muscle membrane potential and redox status differentiates two subgroups of patients with chronic fatigue syndrome. J. Transl. Med. 2020;18:173. doi: 10.1186/s12967-020-02341-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02341-9</ArticleId><ArticleId IdType="pmc">PMC7168976</ArticleId><ArticleId IdType="pubmed">32306967</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J.A.-O., Wood J., Jaycox J.R., Dhodapkar R.A.-O., Lu P.A.-O.X., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139&#x2013;148. doi: 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K. Down-regulation of renin&#x2013;aldosterone and antidiuretic hormone systems in patients with myalgic encephalomyelitis/chronic fatigue syndrome. J. Cardiol. 2017;69:684&#x2013;688. doi: 10.1016/j.jjcc.2016.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jjcc.2016.06.003</ArticleId><ArticleId IdType="pubmed">27401397</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Joffre J., Hellman J. Oxidative Stress and Endothelial Dysfunction in Sepsis and Acute Inflammation. Antioxid. Redox Signal. 2021;35:1291&#x2013;1307. doi: 10.1089/ars.2021.0027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2021.0027</ArticleId><ArticleId IdType="pubmed">33637016</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Kennedy D.J., Yan Y., Shapiro J.I. Reactive Oxygen Species Modulation of Na/K-ATPase Regulates Fibrosis and Renal Proximal Tubular Sodium Handling. Int. J. Nephrol. 2012;2012:381320. doi: 10.1155/2012/381320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/381320</ArticleId><ArticleId IdType="pmc">PMC3299271</ArticleId><ArticleId IdType="pubmed">22518311</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S., Booth N.E., McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2009;2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680051</ArticleId><ArticleId IdType="pubmed">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford G., Manning P., Newton J.L. Understanding Muscle Dysfunction in Chronic Fatigue Syndrome. J. Aging Res. 2016;2016:2497348. doi: 10.1155/2016/2497348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2497348</ArticleId><ArticleId IdType="pmc">PMC4779819</ArticleId><ArticleId IdType="pubmed">26998359</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge O., Mella O., Bruland O., Risa K., Dyrstad S.E., Alme K., Rekeland I.G., Sapkota D., Rosland G.V., Fossa A., et al. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. 2016;1:e89376. doi: 10.1172/jci.insight.89376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.89376</ArticleId><ArticleId IdType="pmc">PMC5161229</ArticleId><ArticleId IdType="pubmed">28018972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>